Published in J Neurol Neurosurg Psychiatry on October 01, 2009
The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol (2011) 0.84
Punctate and curvilinear gadolinium enhancing lesions in the brain: a practical approach. Neuroradiology (2015) 0.81
Immune mediated diseases and immune modulation in the neurocritical care unit. Neurotherapeutics (2012) 0.78
Central nervous system angiitis: a series of 31 patients. Clin Rheumatol (2013) 0.76
Primary angiitis of the central nervous system: a report of three cases from a single colombian center. Case Rep Neurol Med (2013) 0.75
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Relapses and progression of disability in multiple sclerosis. N Engl J Med (2000) 4.17
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain (1980) 3.27
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology (2005) 2.95
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med (2001) 2.68
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (2000) 2.04
Multiple sclerosis: a comparison of the latent periods of different populations. Neuroepidemiology (1993) 1.94
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry (1998) 1.84
Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke (2002) 1.82
Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology (2010) 1.75
Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology (2003) 1.73
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
Persistent ocular motor manifestations and related visual consequences in multiple sclerosis. Ann N Y Acad Sci (2011) 1.52
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci (2009) 1.52
Neuromyelitis optica and pregnancy. Neurology (2012) 1.49
[Genetic study of mucoviscidosis (a personal statistical survey of 273 families)]. Arch Fr Pediatr (1971) 1.47
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. J Neurol Neurosurg Psychiatry (2013) 1.42
Defining the natural history of MS: the need for complete data and rigorous definitions. Mult Scler (2008) 1.41
[Familial epilepsy seizure disclosing long QT syndrome]. Rev Neurol (Paris) (1996) 1.39
Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol (2010) 1.32
Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology (2011) 1.23
Central nervous system cavernomas in the pediatric age group. Neurosurg Rev (2001) 1.19
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol (2002) 1.16
Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler (2009) 1.15
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
Transient neurologic symptoms related to cerebral amyloid angiopathy: usefulness of T2*-weighted imaging. Cerebrovasc Dis (2004) 1.13
Clinical outcomes assessment in multiple sclerosis. Ann Neurol (1996) 1.11
Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology (2006) 1.10
Early detection of cerebral arterial occlusion on magnetic resonance angiography: predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovasc Dis (2002) 1.10
Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol (2003) 1.10
Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol (2011) 1.08
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial. Neurology (2012) 1.05
Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis Sci (1999) 1.02
Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques. AJNR Am J Neuroradiol (2012) 1.02
Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry (2005) 1.01
Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke (2003) 1.01
Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology (2003) 1.01
Diffusion tensor-MRI evidence for extra-axonal neuronal degeneration in caudate and thalamic nuclei of patients with multiple sclerosis. AJNR Am J Neuroradiol (2012) 0.99
[Nephropathies in progressive lipodystrophy or Barraquer-Simons disease]. Ann Pediatr (Paris) (1965) 0.98
Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet (1996) 0.98
[Imaging of osteoarticular tuberculosis]. J Radiol (2002) 0.98
Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes. J Immunol Methods (1993) 0.97
Brain stem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion. AJNR Am J Neuroradiol (2008) 0.96
Temporopolar changes in temporal lobe epilepsy: a quantitative MRI-based study. Neurology (2002) 0.94
Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology (2011) 0.94
[Causes of paralysis of the hypoglossal nerve. Apropos of 32 cases]. Presse Med (1990) 0.92
[Multiple sclerosis and pregnancy]. Rev Neurol (Paris) (2006) 0.92
Spinal cord sarcoidosis: report of seven cases. Eur J Neurol (2009) 0.92
[Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene]. Arch Pediatr (2007) 0.92
DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immunogenetics (1985) 0.91
Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. FASEB J (2006) 0.91
Danazol-induced hepatocellular carcinoma. QJM (2003) 0.90
[Neurological aspects of Fabry's disease]. Rev Neurol (Paris) (2006) 0.90
Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology (2010) 0.90
Complications of percutaneous liver biopsy in infants and children. Eur J Pediatr (1995) 0.89
Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis. J Hepatol (1999) 0.89
Membranous nephropathy and orbital malignant tumor. Pediatr Nephrol (2000) 0.89
[MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations]. Rev Med Interne (2004) 0.88
[Anatomo-clinical study of a case of topographic confabulation (or delusion)]. Cortex (1980) 0.88
Submicroscopic immunodetection of PrP in the brain of a patient with a new-variant of Creutzfeldt-Jakob disease. Neurosci Lett (1999) 0.88
Familial extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1988) 0.87
Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology (2011) 0.87
New variant Creutzfeldt-Jakob disease in France. Lancet (1997) 0.86
Histiocytic sarcoma of the central nervous system: a challenging diagnosis. QJM (2010) 0.86
Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment. Neurology (2007) 0.86
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. Mult Scler (2013) 0.86
Aneurysmal bone cyst of the cervical spine: report of a case investigated by computed tomographic scanning and treated by a two-stage surgical procedure. Neurosurgery (1982) 0.86
[Oculo-palatal myoclonus and multiple sclerosis]. Rev Neurol (Paris) (1990) 0.85
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study. Mult Scler (2011) 0.85
Ultrastructural pathology of prion diseases revisited: brain biopsy studies. Neuropathol Appl Neurobiol (2005) 0.85
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler (2009) 0.85
[Spatial disorientation. Report of 5 cases (author's transl)]. Rev Neurol (Paris) (1981) 0.85
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]. Rev Med Interne (2002) 0.85